BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37256732)

  • 1. Use of 18F-FDG PET/MRI as an Initial Staging Procedure for Nasopharyngeal Carcinoma.
    Cao C; Fang Y; Yu B; Xu Y; Qiang M; Tao C; Huang S; Chen X
    J Magn Reson Imaging; 2024 Mar; 59(3):922-928. PubMed ID: 37256732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
    Xiao BB; Chen QY; Sun XS; Li JB; Luo DH; Sun R; Lin DF; Zhang X; Fan W; Lv XF; Han LJ; Wen YF; Yuan L; Guo SS; Liu LT; Liu SL; Tang QN; Liang YJ; Li XY; Lin C; Guo L; Mai HQ; Tang LQ
    Eur Radiol; 2021 Jul; 31(7):5222-5233. PubMed ID: 33416977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of pre-treatment [
    Dong Z; Wang GY; Dai DY; Qin GJ; Tang LL; Xu C; Ma J
    BMC Cancer; 2024 Apr; 24(1):466. PubMed ID: 38622555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma.
    Liu FY; Lin CY; Chang JT; Ng SH; Chin SC; Wang HM; Liao CT; Chan SC; Yen TC
    J Nucl Med; 2007 Oct; 48(10):1614-9. PubMed ID: 17873135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management.
    Chan SC; Yen TC; Ng SH; Lin CY; Wang HM; Liao CT; Fan KH; Chang JT
    J Nucl Med; 2006 Sep; 47(9):1447-54. PubMed ID: 16954552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 18F-FDG PET/CT as an Initial Staging Procedure for Stage II-III Breast Cancer: A Multicenter Value Analysis.
    Hyland CJ; Varghese F; Yau C; Beckwith H; Khoury K; Varnado W; Hirst GL; Flavell RR; Chien AJ; Yee D; Isaacs CJ; Forero-Torres A; Esserman LJ; Melisko ME
    J Natl Compr Canc Netw; 2020 Nov; 18(11):1510-1517. PubMed ID: 33152704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of simultaneous whole-body
    Chan SC; Yeh CH; Yen TC; Ng SH; Chang JT; Lin CY; Yen-Ming T; Fan KH; Huang BS; Hsu CL; Chang KP; Wang HM; Liao CT
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1297-1308. PubMed ID: 29502310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging.
    Tang LQ; Chen QY; Fan W; Liu H; Zhang L; Guo L; Luo DH; Huang PY; Zhang X; Lin XP; Mo YX; Liu LZ; Mo HY; Li J; Zou RH; Cao Y; Xiang YQ; Qiu F; Sun R; Chen MY; Hua YJ; Lv X; Wang L; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Mai HQ
    J Clin Oncol; 2013 Aug; 31(23):2861-9. PubMed ID: 23857969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology.
    Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Wang HM; See LC; Chen TM; Kang CJ; Wu YF; Lin KJ; Liao CT
    J Nucl Med; 2005 May; 46(5):775-81. PubMed ID: 15872350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis.
    Burian E; Palla B; Callahan N; Pyka T; Wolff C; von Schacky CE; Schmid A; Froelich MF; RĂ¼benthaler J; Makowski MR; Gassert FG
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3870-3877. PubMed ID: 35606526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of [
    Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study.
    Verboom P; van Tinteren H; Hoekstra OS; Smit EF; van den Bergh JH; Schreurs AJ; Stallaert RA; van Velthoven PC; Comans EF; Diepenhorst FW; van Mourik JC; Postmus PE; Boers M; Grijseels EW; Teule GJ; Uyl-de Groot CA;
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1444-9. PubMed ID: 14579081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficiency comparison between PET/CT and conventional work-up for evaluating distant metastasis of nasopharyngeal carcinoma].
    Lin S; Li X; Wu H; Lu J; Liang B; Peng X; Li S; Yu L; Liu X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jun; 26(12):529-32. PubMed ID: 22934422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Zheng J; Liu F; Lin K; Zhang L; Huang N; Zheng W; Zhang J; Yao S; Miao W
    Mol Imaging Biol; 2022 Dec; 24(6):973-985. PubMed ID: 35945360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Cell Lung Cancer Staging: Prospective Comparison of Conventional Staging Tests, FDG PET/CT, Whole-Body MRI, and Coregistered FDG PET/MRI.
    Ohno Y; Yoshikawa T; Takenaka D; Koyama H; Aoyagi K; Yui M; Oshima Y; Hamabuchi N; Tanaka Y; Shigemura C; Oota S; Nomura M; Murayama K; Inui Y; Kikukawa K; Toyama H
    AJR Am J Roentgenol; 2022 May; 218(5):899-908. PubMed ID: 34877872
    [No Abstract]   [Full Text] [Related]  

  • 17. Selectively recommend
    Chen C; Xu T; Qiu X; Xie S; You Z; Hu Y; Zheng Y; Liang Z; Huang C; Chen T; Li L; Liu J; Fei Z
    Radiat Oncol; 2021 Nov; 16(1):229. PubMed ID: 34838075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up.
    Ng SH; Chan SC; Yen TC; Chang JT; Liao CT; Ko SF; Liu FY; Chin SC; Fan KH; Hsu CL
    Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):12-22. PubMed ID: 18704401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant value of
    Peng H; Chen L; Tang LL; Li WF; Mao YP; Guo R; Zhang Y; Liu LZ; Tian L; Zhang X; Lin XP; Guo Y; Sun Y; Ma J
    Chin J Cancer; 2017 Dec; 36(1):95. PubMed ID: 29258597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography scan on initial evaluation of head and neck squamous cell carcinoma: our experience at a tertiary care center in India.
    Nair S; Mohan S; Nilakantan A; Gupta A; Malik A; Gupta A
    World J Nucl Med; 2015; 14(1):19-24. PubMed ID: 25709540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.